Utama › Sindrom Bronkiolitis Obliterans › Michigan
Kajian klinikal Sindrom Bronkiolitis Obliterans di Michigan
7 kajian untuk Sindrom Bronkiolitis Obliterans sedang mencari peserta di lokasi di Michigan.
Bandar di Michigan
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
- Corewell Health Hematology Oncology, Grand Rapids
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Corewell Health, Grand Rapids
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05919511A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Barbara Ann Karmanos Cancer Institute, Detroit
Mengambil pesertaFasa 2
Umur 2 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT04710576BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- University of Michigan, Ann Arbor
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT05922761A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Michigan, Ann Arbor
- Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06615050Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT06419439A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.